CURETIS news, videos and press releases
For more news please use our advanced search feature.
CURETIS - More news...
CURETIS - More news...
- Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report
- Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report
- Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day
- Curetis and OpGen Close Business Combination
- Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update
- Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
- Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020
- Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020
- Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update
- Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam
- Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe
- Curetis to Hold Extraordinary General Meeting on March 10, 2020
- Curetis To Attend Key Conferences in the First Half of 2020
- Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.
- Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens
- Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs
- Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize
- Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens
- Curetis Publishes Third Quarter and 9-Month Business and Financial Update
- Curetis Provides Business Update for the First Nine Months of 2019
- Curetis To Attend Key Conferences in the Fourth Quarter of 2019
- Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test
- Curetis Reports Financial Results for the First Six Months of 2019
- Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation
- Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
- Curetis Retains H.C. Wainwright & Co. as Strategic Advisor
- Curetis Group Company Ares Genetics Launches Service Laboratory for NGS-based Molecular Drug Resistance Testing
- Curetis Elects Share Settlement for Excess Entitlement Under First Tranche of Yorkville Convertible Notes
- Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region
- Curetis to Present at Solebury Trout European Biotech Investor Day in NYC